Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1093/ckj/sft102 http://scihub22266oqcxt.onion/10.1093/ckj/sft102 C4438415!4438415!26120443     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Clin+Kidney+J 2013 ; 6 (5): 500-2 Nephropedia Template TP {{tp|p=26120443|t=2013. Successful treatment of adult-onset collapsing focal segmental glomerulosclerosis with rituximab |pdf=|usr=}}{{26120443}} gab.com Text Successful treatment of adult-onset collapsing focal segmental glomerulosclerosis with rituximab JO: Clin Kidney J http://www.kidney.de/pget.php?&tw=1&pmid=26120443 #FOAvip Collapsing focal segmental glomerulosclerosis (FSGS), or collapsing glomerulopathy (CG), responds poorly to commonly employed therapies, with a high proportion of patients progressing to end-stage renal disease. We report an adult in a nephrotic state, diagnosed with minimal-change disease on biopsy, who failed to respond to steroids, calcineurin inhibitors (CNIs), mycophenolate mofetil and cyclophosphamide. Repeat biopsy showed CG. Treatment with 4 weekly doses of rituximab led to sustained remission of his nephrotic state. This is the first report of adult-onset CG that has responded favourably to rituximab. Rituximab could be a treatment option for patients with this difficult-to-treat condition. Twit Text FOAVip Successful treatment of adult-onset collapsing focal segmental glomerulosclerosis with rituximab ????Clin Kidney J http://www.kidney.de/pget.php?&tw=1&pmid=26120443 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26120443 #FOAvip English Wikipedia <ref>{{Cite pmid|26120443}}</ref> Successful treatment of adult-onset collapsing focal segmental glomerulosclerosis with rituximab #MMPMID26120443 Ramachandran R; Rajakumar V; Duseja R; Sakhuja V; Jha V Clin Kidney J 2013[Oct]; 6 (5): 500-2 PMID26120443show ga Collapsing focal segmental glomerulosclerosis (FSGS), or collapsing glomerulopathy (CG), responds poorly to commonly employed therapies, with a high proportion of patients progressing to end-stage renal disease. We report an adult in a nephrotic state, diagnosed with minimal-change disease on biopsy, who failed to respond to steroids, calcineurin inhibitors (CNIs), mycophenolate mofetil and cyclophosphamide. Repeat biopsy showed CG. Treatment with 4 weekly doses of rituximab led to sustained remission of his nephrotic state. This is the first report of adult-onset CG that has responded favourably to rituximab. Rituximab could be a treatment option for patients with this difficult-to-treat condition. äSuccessful treatment of adult-onset collapsing focal segmental glomeru(epmc).pdf DeepDyve Pubget Overpricing